Annovis Bio, Inc.: Annovis Bio Presents at International Conference on Alzheimer's & Parkinson (AD/PD 2022)

Company Provides Update on Clinical Trial Design of Upcoming Phase 3 Clinical Trials in Parkinson's Disease on March 20, 2022
Berwyn, Pennsylvania--(Newsfile Corp. - March 18, 2022) - Annovis Bio, Inc.

Related Keywords

Berwyn ,Pennsylvania ,United States ,Spain ,Barcelona ,Comunidad Autonoma De Cataluna ,Marial Maccecchini ,Nic Johnson ,Hoehn Yahr ,Annovis Bio ,Linkedin ,Twitter ,International Conference On Alzheimer Parkinson Diseases ,Pennsylvania Newsfile Corp ,Annovis Bio Inc ,Drug Administration ,Russo Partners ,Exchange Commission ,Company Provides Update ,Clinical Trial Design ,Upcoming Phase ,International Conference ,Participant Global Impression ,Down Syndrome ,Annual Report ,Investor Contact ,Annovis ,Presents ,Nternational ,Conference ,Lzheimer ,Parkinson ,022 ,